RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
Clinical trials for RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Time cell therapy tested for Tough-to-Treat blood cancer
Disease control CompletedThis study tested an experimental one-time treatment called KTE-X19 for adults with mantle cell lymphoma, a type of blood cancer, that had returned or stopped responding to other therapies. The treatment involves collecting a patient's own immune cells, modifying them in a lab to…
Matched conditions: RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Experimental immune therapy tested for Tough-to-Treat blood cancer
Disease control CompletedThis study tested an experimental treatment called KTE-X19, a type of CAR T-cell therapy, for adults with mantle cell lymphoma that has returned or stopped responding to other treatments. The treatment involves collecting and genetically modifying a patient's own immune cells to …
Matched conditions: RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC